Weinstock M, Elavalakanar P, Bright S, Ambati SR, et al. Complete responses to odronextamab in two patients with diffuse large B-cell lymphoma refractory to chimeric antigen receptor T-cell therapy. Br J Haematol 2022 Jul 27. doi: 10.1111/bjh.18383.
PMID: 35892294